Ningbo Menovo Pharmaceutical Co., Ltd.

SSE:603538.SS

15.24 (CNY) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12014 Q22014 Q1
Revenue 276.483423.776341.199345.113262.766287.966346.271335.945246.318226.293333.379397.101500.21339.444227.07353.343338.29245.464297.022365.852285.359328.802290.067307.031254.305290.416210.569193.274154.703175.969126.492157.401145.46130.547150.153168.954128.434136.896136.896
Cost of Revenue 189.623278.588218.063260.942167.533213.993221.356236.506169.083144.886209.79220.445297.674209.475144.272215.226219.955168.899188.494216.131185.049194.585175.955199.468157.622179.476141.267138.174113.581114.69790.262100.23293.87577.18199.831100.05584.44290.11790.117
Gross Profit 86.86145.188123.13684.17195.23473.973124.91599.43877.23681.407123.589176.656202.535129.9782.798138.117118.33576.566108.528149.721100.31134.217114.112107.56396.684110.93969.30255.141.12261.27236.2357.16851.58553.36650.32268.89843.99246.77946.779
Gross Profit Ratio 0.3140.3430.3610.2440.3620.2570.3610.2960.3140.360.3710.4450.4050.3830.3650.3910.350.3120.3650.4090.3520.4080.3930.350.380.3820.3290.2850.2660.3480.2860.3630.3550.4090.3350.4080.3430.3420.342
Reseach & Development Expenses 15.01232.64922.10526.53715.82730.94828.72124.04711.5827.12126.92335.5798.53238.2424.10912.75313.21126.87113.17713.8568.14620.79712.23611.0948.83417.7727.77919.2618.05343.6787.01313.357031.577011.94205.1845.184
General & Administrative Expenses 30.71-69.95497.585-13.88841.242-71.97798.078-10.33338.702-64.638106.796-10.52744.583-59.12289.403-15.07337.367-64.53138.951-3.76830.644-33.17835.157-11.47626.275-33.58428.838-11.68621.93-50.80826.005-11.45522.679-51.95624.28822.24323.21917.20717.207
Selling & Marketing Expenses 14.074.61922.02615.4538.71218.14213.09212.1858.01824.85511.1557.7246.898.9586.9438.5514.838-1.0144.6445.2765.4347.0864.3395.234.6756.4034.2085.4082.8576.4373.863.1693.8334.2012.7543.3262.6723.3373.337
SG&A 44.78-65.335119.6111.56549.954-53.834111.171.85246.72-39.783117.95-2.80351.473-50.16496.346-6.52242.205-65.54543.5951.50836.078-26.09239.496-6.24630.95-27.18133.046-6.27824.786-44.37129.865-8.28726.513-47.75427.04325.56925.89120.48620.486
Other Expenses -5.608166.74-73.00820.03-1.271-9.82937.661-38.507-7.733126.006-57.8948.672-0.41-6.20184.485-85.496-0.40285.867-0.375-1.462-0.439-0.851-1.646-3.4992.138-6.257-0.3650.852-0.027-4.992.4972.9940.278.0042.4432.5391.96700
Operating Expenses 54.185136.58768.70975.00265.2980.42787.4872.750.568113.34486.98381.44959.596106.12465.70153.33955.83272.62556.10362.73344.51596.62853.09148.84337.67366.60241.75138.10124.79539.09129.78334.24828.48436.7727.49526.60526.68924.21324.213
Operating Income 32.6768.60154.4277.87521.69-38.49223.238-22.06256.065131.33942.884101.143143.52518.9921.82184.41362.68332.28745.21283.07454.96619.31756.6160.38253.42530.0129.4443.1779.92920.3053.15520.98519.43715.67425.47140.88616.42324.24624.246
Operating Income Ratio 0.1180.020.160.0230.083-0.1340.067-0.0660.2280.580.1290.2550.2870.0560.0960.2390.1850.1320.1520.2270.1930.0590.1950.1970.210.1030.140.2230.0640.1150.0250.1330.1340.120.170.2420.1280.1770.177
Total Other Income Expenses Net -3.792-4.1370.286-0.508-1.271-9.829-0.701-0.146-0.115-15.33-5.511-0.40.08-6.201-0.644-0.366-0.4027.602-1.332-0.802-0.410.519-1.646-3.4992.138-6.257-0.3650.852-0.027-0.537-0.0951.584-0.2033.0422.443-0.4541.5220.570.57
Income Before Tax 28.8834.46454.7137.36720.42-48.32122.537-22.20855.949116.00923.804100.743143.60512.78921.17684.04662.2833.02544.83782.27354.52719.83654.96456.88355.56423.75329.07544.0299.90215.3155.65123.83319.57118.88127.91440.43217.94422.30322.303
Income Before Tax Ratio 0.1040.0110.160.0210.078-0.1680.065-0.0660.2270.5130.0710.2540.2870.0380.0930.2380.1840.1350.1510.2250.1910.060.1890.1850.2180.0820.1380.2280.0640.0870.0450.1510.1350.1450.1860.2390.140.1630.163
Income Tax Expense 5.693-3.8738.2351.9044.649-4.538-2.942-10.4769.731-16.759-5.48922.00416.7912.349-0.27511.7138.43511.178.73613.5948.107-1.5459.1659.8518.976-10.9686.8214.341.5054.4652.2143.024.719-0.5586.1510.3824.0743.6693.669
Net Income 21.2223.55644.3084.89914.043-42.95323.684-12.59543.449124.74629.34369.394115.2637.13519.0466.00650.34526.34533.53263.87943.61722.93941.67244.05242.24231.95219.35137.1797.8679.0812.76719.54813.28217.25121.00928.39312.1917.22317.223
Net Income Ratio 0.0770.0080.130.0140.053-0.1490.068-0.0370.1760.5510.0880.1750.230.0210.0840.1870.1490.1070.1130.1750.1530.070.1440.1430.1660.110.0920.1920.0510.0520.0220.1240.0910.1320.140.1680.0950.1260.126
EPS 0.10.0170.210.0240.07-0.140.11-0.060.210.590.180.420.50.0340.130.450.240.180.160.440.210.160.210.30.210.280.120.280.050.0820.0220.150.0720.160.140.270.0840.110.11
EPS Diluted 0.10.0170.210.0240.07-0.140.1-0.060.20.540.180.420.50.0340.130.450.240.180.160.440.210.160.190.30.210.280.120.280.050.0820.0220.150.0720.160.140.270.0840.110.11
EBITDA 39.23432.03959.96531.69357.026-10.21158.06917.91492.683142.20956.273135.012177.59543.30647.59115.00694.02157.71552.517108.50372.85441.7473.26473.38661.44247.66534.67643.83916.22816.9469.09723.47723.4325.42922.82642.29418.51526.95226.952
EBITDA Ratio 0.1420.0760.1760.0920.217-0.0350.1680.0530.3760.6280.1690.340.3550.1280.210.3250.2780.2350.1770.2970.2550.1270.2530.2390.2420.1640.1650.2270.1050.0960.0720.1490.1610.1950.1520.250.1440.1970.197